From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
In this 90-minute case discussion, participants will discuss a range of hepatitis B case studies with a specialist or experienced hepatitis B s100 prescriber, highlighting approaches to diagnosing, treating and managing people living with hepatitis B.
1.5 CPD hours
Live online
Live online
No upcoming sessions that suit you? Express your interest to be notified if a course is planned in your area.
On completion of this course, participants will be able to:
This activity will be resubmitted to RACGP, ACRRM and ACNP for 2026.
All participants who attend the course in full will be awarded a Statement of Attendance.
Hepatitis B s100 prescribers and other practitioners who see patients living with hepatitis B.
Enhance your clinical decision-making in hepatitis B management with this comprehensive resource. Stay updated and follow the guide to inform decisions in hepatitis B care by accessing this decision making guide.
The fourth edition of B positive has been updated to ensure consistency with the most recent Australian consensus recommendations for the management of hepatitis B (2022).
This form is a platform through which s100 prescribers can submit cases and questions to seek specialist review and advice.
Register your interest in attending this course. You will be contacted when a course is available for your jurisdiction.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
This 50-minute eLearning provides healthcare providers with a practical overview of hepatocellular carcinoma (HCC), which can be caused by chronic viral hepatitis infection. The course explores the HCC care pathway, from understanding risk factors through to patient management, with interactive activities designed to reinforce learning and support best practice in clinical care.
Are you passionate about educating other healthcare professionals on your area of expertise?
Express your interest in speaking at future ASHM courses
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM